SynapCell

J-3 until #AAIC2024 ! Our Scientific Sales Engineer Youness AJRAOUI is on his way to Philadelphia to attend Alzheimer’s Association International Conference. Join us to discuss how to empower drug development in Alzheimer's and Dementia. #Alzheimersresearch #drugdiscovery #SynapCell #CNSdisorder

🌟 Accelerating  Drug Discovery in CNS Disorders 🌟 Billions are invested in drug discovery every year, yet the clinical failure rate remains dauntingly high. We understand the complexities and challenges our sponsors face in developing effective treatments for central nervous system (#CNS) disorders. 🔬 As a forerunner in the field of preclinical EEG, SynapCell benefits from unique expertise and know-how in this domain based on 20 years of experience. We offer a  comprehensive range of assays, from efficacy and derisking assays to model exploration, and ensures that drug candidates are thoroughly evaluated at every stage. Utilizing cutting-edge in vivo compound testing and EEG #biomarkers, we predict the efficacy of drug candidates early in the preclinical phase, significantly increasing the likelihood of clinical success. 🧠 Whether you are working on #epilepsy, #Parkinson’s disease or other movement disorders, #psychiatric and #neurodegenerative disorders, our translational #neuroscience expertise can guide you from discovery to successful clinical outcomes. Discover how SynapCell can revolutionize and accelerate your drug development process. Let's push the boundaries of neuroscience together! 🔗 Learn more about our services : https://synapcell.fr/ #DrugDiscovery #CNSdisorders  #PreclinicalResearch

Absence #epilepsy, #GAERS, #EEG and #fMRI... 👉Find out more about the latest insights! Julien Volle, Grenoble Institut Neurosciences

🚀 Exciting News! SynapCell is Attending AAIC 2024 🚀 We are thrilled to announce that our Scientific Sales Engineer, Youness AJRAOUI, will be attending the Alzheimer's Association International Conference (AAIC) this year! Join us from July 28 to August 1 to explore the latest advancements in Alzheimer's research and discover how SynapCell's innovative solutions can support your drug discovery efforts. Don't miss this opportunity to connect and discuss how we can accelerate breakthroughs in CNS disorders. See you in Philadelphia ! 🌟 #AAIC2024 #AlzheimersResearch #DrugDiscovery #SynapCell #CNSdisorders

🚀🤩🚀 One more! Proud to share this new trophy with you! The Bpifrance Excellence Club brings together France's most innovative growth companies and exceptional leaders from the Bpifrance network to cultivate their boldness and ambitions. Thanks to our innovative #preclinical #EEG technology, which enables us to predict with great precision the efficacy of tomorrow's therapeutic strategies, we are delighted to be contributing to the discovery of potential drugs for brain diseases such as Epilepsy, Parkinson's disease and Schizophrenia. Many thanks to Bpifrance for this recognition, and to our teams and partners - for their commitment, dedication and support - who have made this possible! 👉 www.synapcell.com Corinne Roucard , Yann Roche #CRO #preclinicalEEG #neuroscience #CNS #innovation 📷 Photo credit Branding Artisan, Irina Fedorenco

📢 SynapCell est fière d’annoncer sa participation au #collectif Sesame dans le cadre de son engagement #RSE ! Nous étions présents au premier anniversaire de l’association qui a réuni il y a quelques jours près de 500 personnes au Stade des Alpes à Grenoble. 👉 Un grand merci à Camille Galliard-Minier, Déléguée Générale de Sesame, pour être venue présenter aux collaborateurs de SynapCell les objectifs de cette initiative #solidaire. 👉 L’action de Sesame repose sur une #solidarité territoriale inédite, qui réunit des entreprises, de toutes tailles et de tous secteurs d’activités, installées sur le territoire de la région urbaine (Grésivaudan, Métropole grenobloise et Pays voironnais). La précarité, les violences faites aux femmes, la protection de l’enfance et le handicap sont au cœur des préoccupations du collectif. Les entreprises membres ont pour objectif de fédérer leurs moyens financiers, matériels et humains au service des associations. Soutien financier, missions de bénévolat des salariés, don de matériel, mise à disposition temporaire de biens immobiliers vacants… autant d’actions, de rencontres, d’échanges à venir, au soutien d’une action commune des entreprises et des associations pour aider les plus fragiles dans un environnement local particulièrement porteur en termes de dynamisme économique comme associatif. 👉 Plus d’info sur l’association Sesame ici : https://lnkd.in/e5f4YqNw #association #engagement #Grenoble #gresivaudan #neuroscience #CRO #EEG Yann Roche Corinne Roucard Laetitia Roche Manon Villalba, PhD Anne-Laure FILIPUTTI-GILQUIN

🎉 We are delighted to welcome Maud as a Neuroscientist to the growing SynapCell team!   Over the past 20 years, SynapCell has built up unique know-how in the capture and analysis of #EEG signals, producing advanced translational #electrophysiological #biomarkers relevant to drug discoverers 💊 in assessing the efficacy of molecules at the #preclinical stage. 👉 Welcome to our team of experts, Maud! #eeg #drugdevelopmeent #neuroscience #CNS #CRO

📢🔟 SynapCell celebrates today the ten-year anniversary of its partnership with the University of Utah as the prime contract testing site of the National Institute of Neurological Disorders and Stroke (NINDS) #Epilepsy Therapy Screening Program (ETSP). NINDS is part of the National Institutes of Health. 👉This partnership represents a long-lasting and trustworthy collaboration with the University of Utah and the Anticonvulsant Drug Development (ADD) Program led by Prof. Karen Wilcox. SynapCell and the ADD Program work together in revealing the #antiseizure potential of novel compounds, with a focus on refractory epilepsies affecting millions of people worldwide. 💊Every new anticonvulsant introduced to clinical use in the USA during the past 40 years has been evaluated in this ADD research program. 👉Read the press release to learn more : https://lnkd.in/eu5jSgac Karen Wilcox, Cameron S. Metcalf, PhD, Corinne Roucard, Nicolas Vautrelle #epilepsy #focalepilepsy #MTLE #drugdiscovery #CNS #neurosciences 

📢Meet SynapCell at #BIO2024 June 3-6, 2024, booth #3823, at the San Diego Convention Center, California, and learn more about our expertise and advanced preclinical #EEG solutions for predictive #CNS drug discovery and more! Let's talk about translational #neuroscience and how we can partner to help you reveal the potential of your molecule and maximize your investment. 👉To schedule a meeting, contact Youness AJRAOUI. As a laureate of the Healthcare Innovation France 2030 Plan, SynapCell will be part of the French delegation on booth #3823. France 2030 supports innovative companies at the cutting edge of innovation, presenting revolutionary solutions that promise to shape the future of industry. Many thanks to Lyonbiopôle Auvergne-Rhône-Alpes and Business France for their support! #drugdiscovery #epilepsy #parkinson #autismspectrum #psychiatry

🚀🚀Freshly arrived in California for the SynapCell roadshow!  Hugo Monchal and Youness AJRAOUI are in San Francisco until May 31, 2024, and will be in San Diego from June 3 to 6 at #Bio2024! 👉Let's discuss your expectations and plans, and how SynapCell can leverage its unique expertise and #preclinical #EEG know-how to meet your needs. #preclinicalresearch #epilepsy #eeg #drugdevelopmeent #neuroscience #CNS #CRO